Exploring gene editing as a potential therapeutic strategy for hemophilia
Hemophilia is an inherited bleeding disorder caused by mutations in the F8 or F9 gene, leading to a deficiency or dysfunction of coagulation factors VIII or IX. While current treatments, such as factor replacement, extended half-life factors, and gene therapy, have improved patient outcomes, they ha...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2026-02-01
|
| coleção: | Frontiers in Bioengineering and Biotechnology |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fbioe.2026.1727204/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|